Overview

Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Status:
Completed

Trial end date:
2006-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the appropriate dose, that dose which is found to give maximum effect with limited toxicity, of cisplatin in combination with docetaxel and 5-fluorouracil and then to further define the safety and effectiveness of this combination of medications.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Dana-Farber Cancer Institute

Collaborators:

Brigham and Women's Hospital
Sanofi

Treatments:

Cisplatin
Docetaxel
Fluorouracil